Innovation Pharmaceuticals Inc (IPIX): Invermectin reported as having poor phar...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Saturday, 05/23/2020 11:58:54 AM

Saturday, May 23, 2020 11:58:54 AM

Invermectin reported as having poor pharmacokinetics for use against Covid19 in spite of promising in vitro studies and clinical reports.

GLTA, Farrell

https://www.news-medical.net/news/20200427/Ivermectin-alone-not-useful-in-treating-COVID-19.aspx

https://pubmed.ncbi.nlm.nih.gov/32378737/

https://www.sciencedirect.com/science/article/pii/S0166354220302011

Keep Last Read

Replies (2) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

Only $200 per official company press release!